Page last updated: 2024-08-26

4-hydroxycyclophosphamide and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

4-hydroxycyclophosphamide has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chresta, CM; Crook, TR; Souhami, RL	1

Other Studies

1 other study(ies) available for 4-hydroxycyclophosphamide and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Article	Year
Depletion of cellular glutathione by N,N'-bis(trans-4-hydroxycyclohexyl)-N'-nitrosourea as a determinant of sensitivity of K562 human leukemia cells to 4-hydroperoxycyclophosphamide. Cancer research, 1990, Jul-01, Volume: 50, Issue:13 Topics: Cross-Linking Reagents; Cyclophosphamide; DNA Damage; DNA, Neoplasm; Drug Resistance; Drug Synergism; Glutathione; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Nitrosourea Compounds; Tumor Cells, Cultured	1990

Article

Year

Depletion of cellular glutathione by N,N'-bis(trans-4-hydroxycyclohexyl)-N'-nitrosourea as a determinant of sensitivity of K562 human leukemia cells to 4-hydroperoxycyclophosphamide.

Cancer research, 1990, Jul-01, Volume: 50, Issue:13

Topics: Cross-Linking Reagents; Cyclophosphamide; DNA Damage; DNA, Neoplasm; Drug Resistance; Drug Synergism; Glutathione; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Nitrosourea Compounds; Tumor Cells, Cultured

1990